Martin Albrecht

Research interests: - Ischemia/reperfusion injury - Ischemic and pharmacologic conditioning strategies for organ protection - Animal and ex-vivo models of ischemia/reperfusion injury - Cell culture-based in-vitro hypoxia systems - Mechanisms of stem cell differentiation - Allogeneic and autologous cell therapy - Pluripotent cells of monocytic origin and regulatory macrophages - 3-D bioprinting Professional Affiliation: 2015-present Associate Professor for Experimental Anaesthesiology Department of Anaesthesiology and Intensive Care Medicine University Hospital Schleswig-Holstein, Kiel 2008-present Head of the research group „Experimental Anaesthesiology“ Department of Anaesthesiology and Intensive Care Medicine University Hospital Schleswig-Holstein, Kiel 2006 Habilitation in „Anatomy and Cell Biology“ Ludwig-Maximilians-University Munich 2003-2008 Postdoctoral fellow Institute of Anatomy Ludwig-Maximilians-University Munich 2001-2003 Postdoctoral fellow Institute of Anatomy Philipps-University Marburg Education: 1997-2001 PhD (Dr. rer. physiol.) Philipps-University Marburg 1996-1997 Master of Science (Human Biology) Philipps-University Marburg 1992-1996 Study of Human Biology Philipps-University Marburg Scientific Awards: 2021 German Society for Thoracic and Cardiovascular Surgery, Dr.-Rusche Award (Seniorapplicant) 2016 German Society for Thoracic and Cardiovascular Surgery, Franz J. Köhler Award 2013 German Society for Anaesthesiology and Intensive Care Medicine, Karl Thomas-Award 2007 German Anatomical Society, Wolfgang Bargmann-Award 2003 American Society of Andrology, NIH Trainee Award Funding (selected projects): 2022 Ferring Pharmaceuticals/Trizell S.A. "Transplantation of regulatory macrophages (Mreg) in an ischemic hindlimb mouse model to promote angiogenesis" 2021 German Society for Thoracic and Cardiovascular Surgery "Development of a 3D bioprinting platform for the production of small caliber biological bypass grafts for autologous and allogeneic implantation in cardiovascular surgery" 2020 Ferring Pharmaceuticals/Trizell S.A. „Characterization of human regulatory Macrophages (Mreg)“ 2019 Christian-Albrechts-University of Kiel, intramural grant (Juniorförderung; R. Berndt) „Molecular and cellular mechanisms of hypoxia-induced migration in cultures of human monocytes“ 2017 Ferring Pharmaceuticals/Trizell S.A. „Characterization and differentiation of multipotent cells of monocytic origin“ 2017 Christian-Albrechts-University of Kiel, intramural grant (Anschubfinanzierung) „Cellular mechanisms of cardioprotection: Insights from a culture model of spontaneously contracting inducible pluripotent stem cell (iPSC) derived cardiomyocytes “ 2014 Neurophyxia B.V. „Effects of 2-Imminobiotin on hypoxia-induced cell damage in-vitro” 2013 Christian-Albrechts-University of Kiel, intramural grant (Anschubfinanzierung) „Xenon conditioning for the reduction of intestinal ischemia/reperfusion damage“